Shares of Align Technology Inc. ALGN, -6.69% plunged 18% toward a six-month low in premarket trade Thursday, after the maker of the Invisalign dental product reported better-than-expected third-quarter earnings, but also said average selling prices (ASPs) declined and provided a downbeat outlook. Analyst Richard Newitter at Leerink cut his price target to $320 from $420, but kept his rating at outperform saying the stock selloff is an opportunity to buy. Align said late Wednesday that worldwide ASP was $1,230, down from $1,315 in the second quarter and and from $1,310 in the same period a year ago. Stifel Nicolaus’s Jonathan Block cut his price target to $346 from $425, but affirmed his buy rating saying he does not expect a downward spiral in ASPs. The company said it expects fourth-quarter earnings per share of $1.10 to $1.15 and revenue of $505 million to $515 million. As of the end of September, the FactSet consensus for EPS was $1.32 and for revenue was $545.1 million. The stock has tumbled 24% over the past three months through Wednesday, while the S&P 500 SPX, -3.09% has lost 6.7%.
Have breaking news sent to your inbox. Subscribe to MarketWatch’s free Bulletin emails. Sign up here.